Essa M. Saied | Genetics and Molecular Biology | Research Excellence Award

Assoc. Prof. Dr. Essa M. Saied | Genetics and Molecular Biology | Research Excellence Award

Associate Professor | Humboldt Universität zu Berlin | Germany

Dr. Essa M. Saied is a distinguished researcher at Suez Canal University, Egypt, specializing in medicinal chemistry, molecular pharmacology, and plant genetics. His work focuses on multi-target therapeutic strategies, anticancer drug design, and genetic and epigenetic mechanisms underlying crop resilience. Dr. Saied has authored numerous high-impact publications in leading journals, contributing significantly to advancements in both human health and agricultural sciences. His research integrates in vitro, in vivo, and in silico approaches, fostering innovative solutions for disease management and food security. With extensive collaborations across international research networks, he has advanced knowledge translation from laboratory discoveries to practical applications. His work has had a notable societal impact, particularly in promoting global health, sustainable agriculture, and biofortification strategies.

Citation Metrics (Scopus)

2239
1500
1000
500
0

Citations

2,239

Documents

72

h-index

31

Citations

Documents

h-index

View Google Scholar Profile
View Scopus Profile
View ORCID Profile

Featured Publications

Eui-Kyeong Kim | Biological Sciences | Research Excellence Award

Dr. Eui-Kyeong Kim | Biological Sciences | Research Excellence Award

Research Fellow | Korea National Park Research Institute | South Korea

Dr. Kim Eui-kyeong is a researcher at the Korea National Park Research Institute in Wonju, South Korea, specializing in biological conservation, macrofungal diversity, and ecological monitoring. His work focuses on documenting and preserving fungal species in protected environments, contributing critical data to national biodiversity resources. Kim has collaborated with over twenty co-authors across multidisciplinary projects in mycology, environmental biology, and conservation science. His research on unrecorded macrofungal species provides valuable insights into the diversity and structure of Korea’s fungal ecosystems. Through species assessments, ecological analysis, and evidence-based conservation strategies, he supports sustainable management of national parks and promotes long-term ecological protection and biodiversity awareness. Kim remains committed to advancing scientific understanding and fostering ecological stewardship across communities.

Citation Metrics (Scopus)

17
12
8
4
0

Citations

17

Documents

6

h-index

3

Citations

Documents

h-index

View Scopus Profile

Featured Publications

Patrice X. Petit | Signal Transduction | Best Researcher Award

Dr. Patrice X. Petit | signal transduction | Best Researcher Award

 Research director | Centre National de la Recherche Scientifique | France

Dr. Patrice X. Petit, Doctor ès Sciences and PhD in Biology, is a Research Director at the French National Centre for Scientific Research (CNRS), where he has served since 1979 and established an internationally recognized career in cell biology. Trained at the Université Pierre et Marie Curie and the Université Denis Diderot (Paris), his work has focused on the molecular mechanisms governing cell death, mitochondrial dynamics, oxidative stress, and their implications in cancer biology, immunology, and toxicology. Over more than four decades, he has developed a broad international scientific presence through extensive teaching and research collaborations across Europe, North America, and Asia, including academic engagements with institutions such as the Chinese Academy of Sciences, Caltech, UT Southwestern, the Beatson Cancer Research Center in Glasgow, the University of Madrid, and multiple leading universities throughout Scandinavia, Germany, and France. His scientific leadership is further reflected in his service as an elected member (2016–2020) of the Scientific Council of the CNRS Institute of Biological Sciences (INSB). Dr. Petit has authored 134 scientific publications, accumulating approximately 12,500 citations and an h-index of 44, demonstrating sustained research influence across several biomedical domains, including contributions to plant biology. He is an active peer reviewer for major journals such as Cancer Research, Journal of Cell Biology, PNAS, Oncogene, and Cell Death and Differentiation, and he has served as a grant reviewer for major funding bodies, including the Austrian Academy of Sciences, the French National Research Agency (ANR), EMBO, the Swiss National Science Foundation, and the Fondation pour la Recherche Médicale. His interdisciplinary background—ranging from a formal qualification in history (Université Paris Diderot, 1979) to a DIU in rare diseases (Université de Strasbourg, 2017)—underscores both scientific depth and broader intellectual engagement. Through his sustained research output, international collaborations, and service to the scientific community, Patrice X. Petit has contributed significantly to advancing fundamental and translational knowledge in cell biology, with measurable societal impact across biomedical research and education.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

Zamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., … Petit, P. X. (1995). Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. The Journal of Experimental Medicine, 182(2), 367–377.

Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssière, J. L., Petit, P. X., … Kroemer, G. (1995). Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. The Journal of Experimental Medicine, 181(5), 1661–1672.

Kroemer, G., Petit, P., Zamzami, N., Vayssière, J. L., & Mignotte, B. (1995). The biochemistry of programmed cell death. The FASEB Journal, 9(13), 1277–1287.

Petit, P. X., Lecoeur, H., Zorn, E., Dauguet, C., Mignotte, B., & Gougeon, M. L. (1995). Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. The Journal of Cell Biology, 130(1), 157–167.

Petit, P. X., Susin, S. A., Zamzami, N., Mignotte, B., & Kroemer, G. (1996). Mitochondria and programmed cell death: Back to the future. FEBS Letters, 396(1), 7–13.

Dr. Petit’s work has fundamentally advanced our understanding of mitochondrial biology and programmed cell death, shaping modern concepts of apoptosis, autophagy, and cellular stress responses. His discoveries enabled new biomedical approaches to cancer, immunology, and rare diseases

Ragunath Cholaraj | Biological Sciences | Best Researcher Award

Dr. Ragunath Cholaraj | Biological Sciences | Best Researcher Award

Guest Faculty | Periyar University | India

Dr. Ragunath Cholaraj is a distinguished researcher and academician with extensive expertise in Zoology and Biotechnology, particularly in the field of Aquatic Biotechnology. He holds advanced degrees including dual Master of Science qualifications in Zoology and Biotechnology, an M.Phil., and a Ph.D. from Bharathiar University, where his doctoral research focused on the immunomodulatory effects of fucoidan derived from marine seaweeds on fish immune systems. Professionally, he serves as a Guest Faculty at Periyar University, Salem, and has previously worked as a Research Fellow under the Rashtriya Uchchatar Shiksha Abhiyan (RUSA 2.0) and as a Quality Control Executive at AMEYA Foods (Marico Pvt. Ltd.). His research interests encompass biotechnology, aquaculture, immunology, molecular biology, phytomedicine, cancer biology, nanotechnology, and microbiology. He is proficient in advanced laboratory techniques including molecular diagnostics, nucleic acid analysis, gene expression studies, nanoparticle synthesis, and biochemical assays such as ELISA and Western blotting. As an active journal reviewer for several international journals, he contributes significantly to scholarly peer review. His research accomplishments are reflected in numerous publications in reputed Scopus and SCI-indexed journals, with impactful work on marine bioactive compounds, nanotechnology applications, and immunological studies in aquaculture species. Dr. Ragunath has received several accolades, including the “Young Researcher Award” from the Institute of Scholars and multiple prizes for poster presentations at national and international conferences. His participation in various workshops and faculty development programs highlights his commitment to continuous learning and scientific advancement. Overall, Dr. Ragunath Cholaraj exemplifies a dedicated researcher whose contributions to aquatic biotechnology and interdisciplinary life sciences continue to promote innovation, sustainability, and academic excellence in biological research.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Karthik, M., Ragunath, C., Krishnasamy, P., Paulraj, D. Q., & Ramasubramanian, V. (2023). Green synthesis of zinc oxide nanoparticles using Annona muricata leaf extract and its antioxidant and antibacterial activity. Inorganic Chemistry Communications, 157, 111422. Cited by: 27.

  2. Ragunath, C., Kumar, Y. A. S., Kanivalan, I., & Radhakrishnan, S. (2020). Phytochemical screening and GC-MS analysis of bioactive constituents in the methanolic extract of Caulerpa racemosa (Forssk.) J. Agardh and Padina boergesenii Allender & Kraft. Current Applied Science and Technology, 380–393. Cited by: 26.

  3. Cholaraj, R., & Venkatachalam, R. (2024). Investigation of antioxidant and anticancer potential of fucoidan (in-vitro & in-silico) from brown seaweed Padina boergesenii. Algal Research, 79, 103442. Cited by: 18.

  4. Ragunath, C., & Ramasubramanian, V. (2022). Dietary effect of Padina boergesenii on growth, immune response, and disease resistance against Pseudomonas aeruginosa in Cirrhinus mrigala. Applied Biochemistry and Biotechnology, 1(1), 1–12. Cited by: 13.

  5. Ragunath, C., Kousalya, L., Venkatachalam, R., & Anitha, S. (2022). Green synthesis of hydroxyapatite nanoparticles from Wrightia tinctoria and its antibacterial activity. BioNanoScience, 12(3), 723–730. Cited by: 12.

 

Qiushui Wang | Molecular Biology | Best Researcher Award

Assoc. Prof. Dr. Qiushui Wang | Molecular Biology | Best Researcher Award

Associate Professor| Institute of Analysis and Testing, Beijing Academy of Science and Technology (Beijing Center for Physical and Chemical Analysis) | China

Assoc. Prof. Dr. Qiushui Wang (born August 29, 1991) is a distinguished researcher specializing in biochemistry, molecular biology, and microbial natural products, currently serving as an Associate Research Fellow at the Beijing Center for Physical & Chemical Analysis (BCPCA), Beijing Academy of Science and Technology. She earned her Ph.D. in Biochemistry and Molecular Biology from the Institute of Microbiology, Chinese Academy of Sciences (IMCAS) in 2020 under the supervision of Prof. Zhang Lixin, with part of her doctoral research conducted at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) under Prof. Dr. Rolf Müller. Her academic journey began with a Bachelor’s degree in Pharmacy from Shandong University in 2014. Dr. Wang’s research focuses on microbial natural products, CRISPR/Cas9 gene editing in actinomycetes, microbial diversity, and antibiotic resistance mechanisms. She developed the innovative pQS gene-editing system, significantly improving gene-editing efficiency in rare actinomycetes and enabling new insights into the biosynthesis and yield enhancement of key bioactive compounds such as proxmicin and griselimycin. Her current work integrates multi-omics analysis, high-throughput sequencing, and microbial genomics to explore microbial community dynamics, antibiotic resistance genes, and probiotic strain development for aquaculture and crop health. Dr. Wang has authored several influential publications in journals such as Applied Microbiology and Biotechnology, Frontiers in Microbiology, and Environmental Science. Her research skills include microbial genome engineering, bioinformatics, multi-omics data analysis, natural product discovery, and analytical chemistry (HPLC-MS/MS). She has made remarkable contributions to understanding soil–microbe–crop interactions and antibiotic resistance in aquaculture environments. Recognized for her academic excellence and innovative research, Dr. Wang has received multiple institutional honors and continues to contribute significantly to advancing microbial biotechnology and sustainable environmental health. Her interdisciplinary expertise and leadership mark her as a rising figure in biochemical and microbial research.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate

Featured Publications

  • Wang, Q., Xie, F., Tong, Y., Habisch, R., Yang, B., Zhang, L., Müller, R., & Fu, C. (2020). Dual-function chromogenic screening-based CRISPR/Cas9 genome editing system for actinomycetes. Applied Microbiology and Biotechnology, 104(1), 225–239. Cited by: 27

  • Xie, F., Dai, S., Zhao, Y., Huang, P., Yu, S., Ren, B., Wang, Q., Ji, Z., Alterovitz, G., … (2020). Generation of fluorinated amychelin siderophores against Pseudomonas aeruginosa infections by a combination of genome mining and mutasynthesis. Cell Chemical Biology, 27(12), 1532–1543.e6. Cited by: 16

  • Fu, C., Xie, F., Hoffmann, J., Wang, Q., Bauer, A., Brönstrup, M., Mahmud, T., … (2019). Armeniaspirol antibiotic biosynthesis: Chlorination and oxidative dechlorination steps affording spiro[4.4]non-8-ene. ChemBioChem, 20(6), 764–769. Cited by: 13

  • Xie, F., Dai, S., Shen, J., Ren, B., Huang, P., Wang, Q., Liu, X., Zhang, B., Dai, H., … (2015). A new salicylate synthase AmS is identified for siderophores biosynthesis in Amycolatopsis methanolica 239T. Applied Microbiology and Biotechnology, 99(14), 5895–5905. Cited by: 10

  • Wang, Q., Zhou, X., Liu, Y., Han, Y., Zuo, J., Deng, J., Yuan, L., Gao, L., & Bai, W. (2023). Mixed oligosaccharides-induced changes in bacterial assembly during cucumber (Cucumis sativus L.) growth. Frontiers in Microbiology, 14, 1195096. Cited by: 9

Hywel Williams | Genomic Medicine | Best Researcher Award

Dr. Hywel Williams | Genomic Medicine | Best Researcher Award

Senior Lecturer | Cardiff University | United Kingdom

Dr. Hywel J. Williams is a distinguished academic and researcher currently serving as a Senior Lecturer in Bioinformatics: Genetic and Genomic Medicine in the Division of Cancer and Genetics, School of Medicine, Cardiff University, since 2019. He holds a Ph.D. in Genetics from Cardiff University (2001–2005), where his research focused on identifying schizophrenia susceptibility genes on chromosome 22 under the supervision of Prof. Sir Michael J. Owen. His earlier academic qualifications include a B.Sc. (Hons) in Genetics from Cardiff University (1994–1996) and an HND in Applied Biology from the University of Wales Institute Cardiff (1992–1994). Dr. Williams also earned recognition as an Associate Fellow of the Higher Education Academy in 2018. With over two decades of research experience, his career spans roles such as Senior Research Associate at UCL’s Great Ormond Street Institute of Child Health (2013–2018), and various research positions at Cardiff University from 1997 to 2012. His work integrates bioinformatics, genomics, and molecular genetics, with a primary focus on rare diseases, psychiatric genetics, and genomic medicine. His key contributions include joint first authorship of the landmark study “The 100,000 Genomes Pilot on Rare Disease Diagnosis in Healthcare” published in the New England Journal of Medicine (2021), and senior authorship in studies enhancing rapid pediatric sequencing and understanding of genetic disorders. Dr. Williams possesses advanced research skills in genomic data analysis, variant interpretation, computational biology, and multi-omic integration, contributing to the clinical translation of genome sequencing technologies. With an outstanding academic record—over 19,000 citations, an h-index of 56, and an i10-index of 101—he is recognized for his influential work in genomic research and data-driven healthcare. His career reflects a commitment to improving diagnostic accuracy and patient care through innovative bioinformatics approaches, making him a key contributor to the global advancement of precision and personalized medicine.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Purcell, S. M., Wray, N. R., Stone, J. L., Visscher, P. M., O’Donovan, M. C., Sullivan, P. F., Williams, H. J., et al. (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 460(7256), 748–752. https://doi.org/10.1038/nature08185 Cited by: 5,521

  2. Schizophrenia Working Group of the Psychiatric Genomics Consortium. (2011). Genome-wide association study identifies five new schizophrenia loci. Nature Genetics, 43(10), 969–976. https://doi.org/10.1038/ng.940 Cited by: 2,110

  3. Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., et al. (2014). De novo mutations in schizophrenia implicate synaptic networks. Nature, 506(7487), 179–184. https://doi.org/10.1038/nature12929 Cited by: 1,920

  4. O’Donovan, M. C., Craddock, N., Norton, N., Williams, H., Peirce, T., Moskvina, V., et al. (2008). Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nature Genetics, 40(9), 1053–1055. https://doi.org/10.1038/ng.201 Cited by: 1,327

  5. 100,000 Genomes Project Pilot Investigators (including Williams, H. J.). (2021). 100,000 genomes pilot on rare-disease diagnosis in health care—preliminary report. New England Journal of Medicine, 385(20), 1868–1880. https://doi.org/10.1056/NEJMoa2035790 Cited by: 657

Harpal Buttar | Molecular Biology | Best Researcher Award

Prof. Dr. Harpal Buttar | Molecular Biology | Best Researcher Award

Adjunct Professor | University of Ottawa | Canada

Prof. Dr. Harpal S. Buttar, D.V.M., M.Sc., Ph.D., FICN, FIACS, FSPER, is an internationally recognized biomedical scientist with expertise in pharmacology, reproductive and developmental toxicology, cardiovascular sciences, and clinical nutrition. He received his Doctor of Veterinary Medicine (D.V.M.) degree from Hissar, India, followed by an M.Sc. and Ph.D. in Pharmacology from the University of Alberta, Canada. With over 41 years of distinguished professional service, he worked as Senior Research Scientist and Assessment Officer at Health Canada, the Canadian counterpart of the US-FDA, while also serving as Adjunct Professor in the Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of Ottawa. His current research focuses on functional foods, nutraceuticals, probiotics, dysbiosis, bioactive components of bovine colostrum, biomarkers of oxidative stress, drug metabolism, Mediterranean diet, and preventive strategies against cardiovascular diseases, obesity, diabetes, and other chronic disorders. He has strong research skills in clinical nutrition, toxicology, drug development, food-drug interactions, and biomedical applications of nanotechnology, with extensive collaborations across Canada, India, Europe, Asia, and the United States. Dr. Buttar has authored 162 peer-reviewed publications, 70 book chapters, and one monograph, with 98 citations from 4 indexed documents and an h-index of 4 (ResearchGate also lists his wider body of work with 4,067 citations and h-index 30). He has been honored with numerous awards, including fellowships from the International College of Nutrition, International Academy of Cardiovascular Sciences, and the Society of Pharmaceutical Education and Research, as well as the Special Recognition Award from the Society for Ethnopharmacology of India. He also has an oration award named after him by IACS India Section in recognition of his global leadership. In conclusion, Dr. Buttar’s outstanding contributions to biomedical sciences, preventive healthcare, and international research collaborations, coupled with his lifelong dedication to mentoring and innovation, make him a highly deserving candidate for prestigious recognition and awards worldwide.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  1. Kumari, A., Singh, S. P., Kumar, P., Yadav, V., & colleagues. (2025, September). A comprehensive review of the epidemiology, pathophysiology, risk factors, and treatment strategies for retinoblastoma.

  2. Wilson, D. W., Gouda, M., De Meester, F., Buttar, H., & colleagues. (2025, June). Nanotherapies for the prevention and treatment of diet- and genetic-related diseases: A systematic review.

  3. Wilson, D. W., Griffiths, K., De Meester, F. M., Sak, K., & colleagues. (2025, June). Polyphenols in plants and impact on human health: Relevance to adaption to global climate change: An overview.

  4. Miran, M., Kamandloo, F., Salami, M., Wilson, D. W., & colleagues. (2025, May). Pathophysiology of diabetes-induced complications: A systematic review concerning the preventive role of dietary polyphenols, probiotics and physical activity.

  5. Gholami, M., Salmani, R. H. G., Madadlou, S. K., Kaur, P., & colleagues. (2025, May). Antidepressant effects of medicinal plants and their pharmacologically active ingredients: A systematic review focused on the serotonergic system.

Adem Güner | Molecular Biology | Best Researcher Award

Assoc. Prof. Dr. Adem Güner | Molecular Biology | Best Researcher Award

Corresponding Author at Sinop University, Turkey

Assoc. Prof. Dr. Adem Güner is an accomplished academic specializing in biology, toxicology, cancer research, and occupational health & safety. His career reflects a strong interdisciplinary approach, integrating fundamental biological sciences with applied health innovations. He has contributed extensively to scientific research through publications in high-impact journals, covering cancer biology, nanoparticle synthesis, apoptosis mechanisms, and environmental toxicology. Early in his career, Dr. Güner explored the biological activities of marine algae and lichens, highlighting their cytotoxic, antioxidant, and protective roles. More recently, he has advanced into occupational safety research, incorporating modern tools such as virtual reality-based risk assessment and accident process management. Beyond publications, he has demonstrated leadership through departmental responsibilities, supervision of students, and participation in nationally funded projects. His active involvement in professional organizations such as EACR and MOKAD, alongside community-impact projects, further illustrates his commitment to advancing both academic knowledge and societal well-being at local and international levels.

Professional Profile 

Google Scholar | Scopus Profile | ORCID Profile 

Education

Assoc. Prof. Dr. Adem Güner holds a strong academic background with progressive degrees in biology. He earned his Master’s degree in General Biology from Atatürk University, where he laid the foundation for his interest in cellular biology and toxicology. He then pursued doctoral research at Ege University, obtaining his Ph.D. in General Biology. During his doctoral studies, he focused on exploring the cytotoxic, antioxidant, and genoprotective properties of marine algae and lichens, producing work that connected natural product research with cancer biology. His academic training was not limited to laboratory work but also extended into applied aspects of occupational health, environmental biology, and molecular research. This educational journey has enabled him to develop expertise in both experimental biology and applied health sciences. The combination of fundamental biological studies and applied technological solutions reflects his broad perspective on using education as a bridge between science and practice.

Experience

Assoc. Prof. Dr. Güner has accumulated over a decade of academic and research experience across respected Turkish universities. He began his career as a Research Assistant at Giresun University, where he gained foundational experience in teaching, laboratory management, and collaborative research. Later, he joined Sinop University’s Faculty of Health Sciences, where he progressed through the roles of Assistant Professor and now Associate Professor. In these roles, he has conducted impactful studies in cancer research, toxicology, nanoparticle applications, and occupational safety. His involvement as a project leader and researcher in nationally funded programs, including those supported by TÜBİTAK, has strengthened his expertise in grant management and interdisciplinary teamwork. As Vice Chair of his department, he has contributed to academic governance and curriculum development. Dr. Güner’s experience also extends internationally, with memberships in leading associations such as EACR and MOKAD, which have enabled him to remain connected with global scientific advancements and collaborations.

Research Interest

Assoc. Prof. Dr. Adem Güner’s research interests span multiple disciplines, reflecting his interdisciplinary expertise. In the field of cancer biology, he investigates cytotoxicity, apoptosis, and molecular mechanisms of natural and synthetic compounds, focusing on their potential as anticancer agents. His early studies on marine algae and lichens emphasized their antioxidant and protective activities against genotoxic and oxidative stress. He also explores the role of nanoparticle synthesis in biomedical applications, especially for drug delivery and therapeutic purposes. Beyond cancer research, Dr. Güner has a strong interest in environmental toxicology, studying the effects of pollutants and chemicals on human health. More recently, his focus has expanded into occupational health and safety, where he applies innovative technologies such as virtual reality-based risk assessment and accident process modeling to prevent workplace hazards. This diverse range of interests highlights his dedication to combining fundamental biology with real-world applications, ultimately advancing both scientific understanding and societal health.

Award and Honor

Throughout his career, Dr. Adem Güner has earned recognition for his academic and research contributions in biology, toxicology, and health sciences. His research excellence has been acknowledged through nationally funded grants and projects, including support from TÜBİTAK, which underscores his ability to secure competitive funding and lead impactful investigations. As a dedicated academic, he has supervised student theses and guided young researchers, further enhancing his professional standing. His leadership roles, such as serving as Vice Chair of his department, demonstrate institutional recognition of his organizational and academic capabilities. Dr. Güner’s membership in esteemed international organizations such as The European Association for Cancer Research (EACR) and Molecular Cancer Research Association (MOKAD) reflects peer recognition of his scientific contributions and his integration into the global research community. These honors and affiliations collectively highlight his academic impact, leadership potential, and ongoing commitment to advancing research with both scientific and societal benefits.

Research Skills

Assoc. Prof. Dr. Adem Güner possesses a versatile set of research skills that combine experimental, analytical, and applied methodologies. He is proficient in cell culture techniques, cytotoxicity assays, and apoptosis analysis, enabling him to evaluate anticancer activities of natural and synthetic compounds. His expertise extends to nanoparticle synthesis and characterization, particularly in biomedical applications, and he has conducted detailed investigations in environmental toxicology, examining pollutant impacts on health. Dr. Güner also demonstrates strong skills in molecular biology techniques, including oxidative stress analysis and genotoxicity evaluation. Beyond laboratory expertise, he is adept in project management and grant acquisition, having led and contributed to multiple TÜBİTAK-funded projects. In recent years, he has developed applied research skills in virtual reality-based occupational risk assessment and accident prevention modeling, showcasing his adaptability in adopting modern technologies. His comprehensive skill set reflects not only technical proficiency but also an ability to integrate science into innovative health and safety applications.

Publication Top Notes

Title: Novel benzimidazole derivatives: Synthesis, in vitro cytotoxicity, apoptosis and cell cycle studies
Authors: H. Atmaca, S. İlhan, M.B. Batır, Ç.Ç. Pulat, A. Güner, H. Bektaş
Year: 2020
Citation: 51

Title: Multi-Biomarker Responses After Exposure to Pollution in the Mediterranean Mussels (Mytilus galloprovincialis L.) in the Aegean Coast of Turkey
Authors: D. Ozkan, M. Dagdeviren, S. Katalay, A. Guner, N.Ü.K. Yavaşoğlu
Year: 2017
Citation: 39

Title: Antimicrobial and antioxidant activities with acute toxicity, cytotoxicity and mutagenicity of Cystoseira compressa (Esper) Gerloff & Nizamuddin from the coast of Urla
Authors: A. Güner, C. Köksal, Ş.B. Erel, H. Kayalar, A. Nalbantsoy, A. Sukatar, …
Year: 2015
Citation: 38

Title: Apoptosis-inducing activities of Halopteris scoparia L. Sauvageau (Brown algae) on cancer cells and its biosafety and antioxidant properties
Authors: A. Güner, A. Nalbantsoy, A. Sukatar, N.Ü. Karabay Yavaşoğlu
Year: 2019
Citation: 35

Title: Histopathological and apoptotic changes on marine mussels Mytilus galloprovincialis (Lamark, 1819) following exposure to environmental pollutants
Authors: A. Yavaşoğlu, D. Özkan, A. Güner, S. Katalay, F. Oltulu, N.Ü.K. Yavaşoğlu
Year: 2016
Citation: 32

Title: Anticancer and antiangiogenesis activities of novel synthesized 2-substituted benzimidazoles molecules
Authors: A. Güner, E. Polatli, T. Akkan, H. Bektaş, C. Albay
Year: 2019
Citation: 20

Title: Ameliorative effect of edible Halopteris scoparia against cadmium‐induced reproductive toxicity in male mice: A biochemical and histopathologic study
Authors: Ö. Güner, A. Güner, A. Yavaşoğlu, N.Ü. Karabay Yavaşoğlu, O. Kavlak
Year: 2020
Citation: 16

Title: The cytogenetic effects of the aqueous extracts of migratory locust (Locusta migratoria L.) in vitro
Authors: H. Turkez, Ü. İncekara, A. Güner, E. Aydın, E. Dirican, B. Togar
Year: 2014
Citation: 16

Title: Apoptosis-inducing activity of safflower (Carthamus tinctorius L.) seed oil in lung, colorectal and cervix cancer cells
Authors: A. Güner, S. Kızılşahin, A. Nalbantsoy, N.Ü. Karabay Yavaşoğlu
Year: 2020
Citation: 15

Conclusion

In conclusion, Assoc. Prof. Dr. Adem Güner is highly suitable for the Best Researcher Award. His extensive contributions in cancer biology, toxicology, and occupational safety research—supported by impactful publications, funded projects, and academic mentorship—demonstrate a career dedicated to advancing both scientific knowledge and societal well-being. With his proven ability to integrate basic science with applied health technologies, he not only enriches the academic community but also addresses real-world challenges in health and safety. His future potential for leadership in international collaborations and innovative research makes him a deserving candidate for this award.

Mohammed A. M. Alhoot | Molecular Microbiology | Outstanding Scientist Award

Assoc. Prof. Dr. Mohammed A. M. Alhoot | Molecular Microbiology | Outstanding Scientist Award

Associate Professor of Medical Microbiology & Immunology at Management and Science University, Malaysia

Assoc. Prof. Dr. Mohammed AbdelFatah Mosa Al-Hoot is an accomplished academic and researcher in Medical Microbiology and Immunology, specializing in Virology and Molecular Microbiology. With a career spanning over two decades, he has made significant contributions to molecular virology, antiviral therapeutics, antimicrobial resistance, nanoparticle-based treatments, and infectious diseases. His research on dengue virus inhibition through siRNA and antiviral peptides, as well as nanoparticle antibacterials and phytochemical antiviral screening, has been widely recognized. He has authored more than 40 peer-reviewed publications, contributed book chapters, and holds a patent, with his work attracting over 600 citations globally. A leader in postgraduate supervision, curriculum development, and research ethics, Dr. Al-Hoot also serves as an editor and reviewer for international journals. His collaborative projects across countries, commitment to capacity building, and contributions to scientific knowledge have positioned him as a respected figure in the global research community.

Professional Profile 

Google Scholar | Scopus Profile | ORCID Profile 

Education

Dr. Al-Hoot’s academic journey reflects a strong foundation in medical sciences and research excellence. He earned his Bachelor’s degree with honors in Medical Laboratory Sciences, followed by a Master’s in Microbiology, both of which equipped him with essential skills in laboratory diagnostics and infectious disease analysis. Building on this expertise, he pursued and completed a Ph.D. in Medical Microbiology, specializing in Medical Virology, at a leading university. His doctoral research focused on innovative antiviral strategies, laying the groundwork for his subsequent contributions to molecular virology and translational therapeutics. Throughout his education, Dr. Al-Hoot consistently demonstrated academic distinction, earning scholarships and recognition for his scholarly performance. His academic qualifications have provided a strong platform for his research in virology, antimicrobial resistance, and nanoparticle therapeutics, enabling him to bridge fundamental science with applied biomedical solutions. His education has also shaped his teaching and mentorship, fostering future leaders in the microbiology and biomedical fields.

Experience

Dr. Al-Hoot’s professional career spans extensive academic, research, and clinical laboratory roles, reflecting his versatility and leadership in medical microbiology. He has served as an Associate Professor at a reputed Malaysian university, where he has been actively involved in teaching, research supervision, curriculum coordination, and academic leadership. His experience includes managing and leading numerous research projects, both as principal investigator and collaborator, with international partners. Over the years, he has successfully supervised numerous Ph.D. and Master’s students to completion, contributing to global research capacity building. His professional journey also encompasses significant editorial and peer review responsibilities for high-impact scientific journals, ensuring the quality of published research in his field. In addition to his academic work, he has engaged in community outreach, research ethics committees, and scientific event organization. This multifaceted experience underscores his ability to integrate research, teaching, and service for impactful contributions to science and society.

Research Interest

Dr. Al-Hoot’s research interests lie at the intersection of molecular virology, antimicrobial resistance, and innovative therapeutic approaches. He focuses on developing antiviral strategies targeting viral entry and replication, particularly for dengue virus and other significant pathogens. His work explores the use of small interfering RNA (siRNA), synthetic antiviral peptides, and natural products as novel therapeutics. Additionally, he investigates nanoparticle-based antibacterial agents and their role in combating drug-resistant microorganisms. His interests also extend to diagnostic microbiology, infectious diseases, and gut microbiota modulation. By integrating molecular biology techniques with translational applications, Dr. Al-Hoot aims to address global health challenges through innovative, sustainable, and effective solutions. His interdisciplinary research approach fosters collaboration between microbiology, nanotechnology, pharmacology, and clinical sciences, ensuring that his work remains relevant to both scientific advancement and public health needs. These interests continue to guide his projects, publications, and mentorship of emerging researchers in the field.

Awards and Honors

Dr. Al-Hoot’s excellence in research and academia has been recognized through numerous awards and honors. He has received the University of Malaya Excellence Award for his outstanding contributions to scientific research, as well as prestigious scholarships, including the MIS Scholarship during his doctoral studies. His institution has honored him with multiple service excellence recognitions, acknowledging his dedication to teaching, research, and community service. He has been invited as a keynote speaker and panelist at international conferences, reflecting the high regard for his expertise in virology and antimicrobial research. His editorial roles in globally recognized journals and active involvement in peer review further underscore his professional standing. Additionally, his contributions to collaborative projects and research ethics committees have earned him respect within the academic community. These accolades not only celebrate his past achievements but also highlight his continuing commitment to advancing microbiology and immunology for societal benefit.

Research Skills

Dr. Al-Hoot possesses a diverse and advanced skill set in medical microbiology, molecular virology, and infectious disease research. His technical expertise includes RNA interference, synthetic antiviral peptide development, nanoparticle synthesis for antimicrobial applications, molecular diagnostics, and advanced microbiological assays. He is proficient in designing and conducting translational research studies that bridge laboratory findings to clinical applications. His skills extend to grant writing, securing competitive funding, and leading multi-institutional and international research collaborations. In the academic sphere, he excels in curriculum design, postgraduate supervision, and mentorship, fostering the next generation of researchers. His editorial and peer-review experience with high-impact journals demonstrates his ability to critically evaluate scientific work and maintain research integrity. Additionally, his involvement in organizing scientific conferences and workshops highlights his capabilities in knowledge dissemination and community engagement. Collectively, these skills enable him to contribute significantly to both scientific discovery and the broader biomedical research ecosystem.

Publications Top Notes

Title: Autophagy and Senescence: A New Insight in Selected Human Diseases
Authors: P. Rajendran, A.M. Alzahrani, H.N. Hanieh, S.A. Kumar, R. Ben Ammar, M.A. Alhoot, and others
Year: 2019
Citations: 128

Title: Inhibition of Dengue Virus Entry into Target Cells Using Synthetic Antiviral Peptides
Authors: M.A. Alhoot, A.K. Rathinam, S.M. Wang, R. Manikam, S.D. Sekaran
Year: 2013
Citations: 83

Title: Inhibition of Dengue Virus Entry and Multiplication into Monocytes Using RNA Interference
Authors: M.A. Alhoot, S.M. Wang, S.D. Sekaran
Year: 2011
Citations: 70

Title: RNA Interference Mediated Inhibition of Dengue Virus Multiplication and Entry in HepG2 Cells
Authors: M.A. Alhoot, S.M. Wang, S.D. Sekaran
Year: 2012
Citations: 66

Title: Isolation and Screening of Extracellular Protease Enzyme from Fungal Isolates of Soil
Authors: A.M.A. Maitig, M.A.M. Alhoot, K. Tiwari
Year: 2018
Citations: 50

Title: Genetic Diversity of Fungi Producing Mycotoxins in Stored Crops
Authors: F.E.M. Eltariki, K. Tiwari, I.A. Ariffin, M.A. Alhoot
Year: 2018
Citations: 23

Title: An Association between Khat and Diabetes
Authors: A.M. El Hadrani, M.A. Alhoot
Year: 2000
Citations: 23

Title: Climate Change and Health: The Malaysia Scenario
Authors: M.A. Alhoot, W.T. Tong, W.Y. Low, S.D. Sekaran
Year: 2016
Citations: 21

Conclusion

Assoc. Prof. Dr. Mohammed AbdelFatah Mosa Al-Hoot is a distinguished scientist in Medical Microbiology and Immunology, with specialization in Virology and Molecular Microbiology. His research covers molecular virology, antiviral therapeutics, antimicrobial resistance, nanoparticle-based treatments, and infectious diseases, with notable work on dengue virus inhibition through siRNA and antiviral peptides, as well as nanoparticle antibacterials and phytochemical antiviral screening. He holds advanced degrees in medical microbiology and has extensive academic and clinical experience, contributing significantly to education and research. He has led and collaborated on multiple funded projects across several countries, producing over 40 peer-reviewed publications, book chapters, and a patent, with substantial citations. Serving as an editor and reviewer for international journals, he actively advances research quality. His leadership includes curriculum development, postgraduate supervision, ethics committee service, and organizing academic events. Dedicated to mentorship, collaboration, and innovation, he has made impactful contributions to science, capacity building, and the global research community.

Stanislav Naryzhny | Proteomics | Best Researcher Award

Prof . Stanislav Naryzhny | Proteomics | Best Researcher Award

Leading Scientist at PNPI, Russia

Dr. Stanislav Naryzhny is a distinguished protein biochemist with over four decades of dedicated research in biochemistry, proteomics, and molecular biology. He holds both Ph.D. and D.Sc. degrees in Biology, specializing in biochemistry. As a Leading Scientist at the St.-Petersburg Nuclear Physics Institute and an Adjunct Professor at Laurentian University, Canada, Dr. Naryzhny has significantly contributed to understanding DNA replication, proteoform diversity, and tumor marker identification. He is renowned for his technical expertise in mass spectrometry, protein purification, and proteome mapping, with an extensive record of high-impact publications. His work bridges fundamental research with practical applications, evident in his innovations and patents related to DNA and protein fractionation. A recipient of numerous research grants and institutional awards, Dr. Naryzhny remains an influential figure in biochemical research. His exceptional communication skills, collaborative approach, and leadership in international academic settings make him a highly suitable candidate for the Best Researcher Award.

Professional Profile 

Education🎓

Dr. Stanislav Naryzhny’s academic journey reflects a deep-rooted commitment to the life sciences. He earned his Master’s degree in Biophysics from Tbilisi State University in Georgia in 1974, establishing a strong foundation in molecular and structural biology. He later pursued his Ph.D. in Biology, specializing in Biochemistry and Radiobiology, awarded by the Russian Academy of Sciences in 1984. Building on his doctoral work, he attained a Doctor of Science (D.Sc.) degree in Biology with a focus on Biochemistry, further solidifying his expertise in protein structure-function relationships and DNA repair mechanisms. In addition to his formal academic qualifications, Dr. Naryzhny completed postdoctoral training at the Northeastern Ontario Regional Cancer Centre in Canada, where he deepened his research on cell and molecular biology, particularly in DNA replication and cell-cycle proteomics. He also holds certifications in MALDI mass spectrometry operation and health and safety training, reflecting his multidisciplinary capabilities and continuous professional development.

Professional Experience📝

Dr. Naryzhny brings a rich professional background spanning over 45 years, with significant contributions to both Russian and Canadian research institutions. He began his career in the 1970s at the St.-Petersburg Nuclear Physics Institute (PNPI), Russian Academy of Sciences, where he steadily advanced through research roles, eventually becoming a Leading Scientist in 2010. His research has primarily focused on DNA repair, replication mechanisms, and proteomics. From 1999 to 2009, he worked in Canada as a Postdoctoral Researcher and later Associate Scientist at the Northeastern Ontario Regional Cancer Centre and Sudbury Regional Hospital, focusing on cell-cycle regulation and proteome analysis. Since 2008, he has served as an Adjunct Professor in the Department of Chemistry and Biochemistry at Laurentian University, engaging in academic collaboration and student mentorship. His experience includes managing research teams, conducting grant-funded projects, and developing new methodologies in protein biochemistry, establishing him as a leader in his field.

Research Interest🔎

Dr. Naryzhny’s research interests lie at the intersection of protein biochemistry, cellular proteomics, and DNA replication machinery. His primary focus is on understanding the molecular structure and functional diversity of proteoforms, especially in the context of cancer diagnostics. He has conducted pioneering work on the role of PCNA (proliferating cell nuclear antigen) in coordinating multiple cellular functions and its implications in tumorigenesis. His studies extend to the structural and dynamic organization of DNA replication machinery, particularly in mammalian cells. He has also explored the development and application of 2D electrophoresis-based proteomic profiling techniques, which have implications in identifying novel tumor biomarkers such as haptoglobin proteoforms in glioblastoma. His work bridges biophysical analysis, bioinformatics, and translational science, with an emphasis on improving the understanding of the cell cycle and protein expression under both normal and pathological conditions. His contributions continue to shape the field of proteome-based disease diagnosis and therapy.

Award and Honor🏆

Dr. Naryzhny has received numerous prestigious awards and honors in recognition of his outstanding scientific contributions. Notably, he has been a recipient of multiple grants from the Russian Science Foundation, the Russian Fund of Fundamental Investigations, and the International Science Foundation, highlighting his sustained research excellence. His work has been supported by Canadian institutions such as the NCIC, and he has received internal awards from the St.-Petersburg Nuclear Physics Institute across several years. He was also recognized at the Keystone Symposium and received honors for poster presentations at international conferences. His early contributions were celebrated with PNPI awards dating back to the 1970s and 1980s. These accolades underscore his global recognition and influence in the fields of biochemistry and molecular biology. Dr. Naryzhny’s consistent ability to secure competitive research funding and academic distinction showcases his impact and dedication, making him a deserving recipient of accolades such as the Best Researcher Award.

Research Skill🔬

Dr. Stanislav Naryzhny possesses an expansive and versatile skill set that underpins his innovative biochemical research. He is an expert in mass spectrometry, 2D electrophoresis, protein expression and purification, Western and Far-Western blotting, and HPLC techniques, all essential for high-level proteomic studies. His proficiency in cell biology includes tissue culture, transfection, confocal microscopy, FACS, and immunocytochemistry. In immunology, he has developed polyclonal antibodies and has extensive experience in laboratory animal handling. On the computational front, he is skilled in using various bioinformatics tools for proteomics and genomics, along with molecular modeling and database analysis. His knowledge extends to software such as GraphPad Prism, Swiss-PdbViewer, and Phoretix 2D. Beyond the lab, Dr. Naryzhny also has skills in scientific visualization and poster design. This diverse technical repertoire supports his groundbreaking research and positions him as a highly skilled and adaptable scientist in the rapidly evolving field of molecular and cellular biology.

Conclusion💡

Dr. Stanislav Naryzhny is highly suitable for the Best Researcher Award, particularly due to his:

  • Long-standing contributions to biochemistry and proteomics

  • Consistent publication in high-quality journals

  • Leadership in both Russian and Canadian scientific communities

  • Technological innovations and applied research

While the profile could be enhanced with recent citation metrics and global leadership roles, his lifetime achievement, ongoing productivity, and technical depth make him a strong and deserving candidate for this recognition.

Publications Top Noted✍

  • Title: Proliferating cell nuclear antigen: a proteomics view
    Authors: SN Naryzhny
    Year: 2008
    Citations: 317

  • Title: The post-translational modifications of proliferating cell nuclear antigen: acetylation, not phosphorylation, plays an important role in the regulation of its function
    Authors: SN Naryzhny, H Lee
    Year: 2004
    Citations: 155

  • Title: Proliferating cell nuclear antigen in the cytoplasm interacts with components of glycolysis and cancer
    Authors: SN Naryzhny, H Lee
    Year: 2010
    Citations: 115

  • Title: Proliferating cell nuclear antigen (PCNA) may function as a double homotrimer complex in the mammalian cell
    Authors: SN Naryzhny, H Zhao, H Lee
    Year: 2005
    Citations: 94

  • Title: The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalences in cervical cancer
    Authors: C Richard, C Lanner, SN Naryzhny, L Sherman, H Lee, PF Lambert, …
    Year: 2010
    Citations: 92

  • Title: Chromosome 18 transcriptome profiling and targeted proteome mapping in depleted plasma, liver tissue and HepG2 cells
    Authors: VG Zgoda, AT Kopylov, OV Tikhonova, AA Moisa, NV Pyndyk, …
    Year: 2013
    Citations: 79

  • Title: Characterization of proliferating cell nuclear antigen (PCNA) isoforms in normal and cancer cells: there is no cancer-associated form of PCNA
    Authors: SN Naryzhny, H Lee
    Year: 2007
    Citations: 75

  • Title: Proteome of glioblastoma-derived exosomes as a source of biomarkers
    Authors: S Naryzhny, A Volnitskiy, A Kopylov, E Zorina, R Kamyshinsky, …
    Year: 2020
    Citations: 64

  • Title: Chromosome-centric approach to overcoming bottlenecks in the Human Proteome Project
    Authors: A Archakov, V Zgoda, A Kopylov, S Naryzhny, A Chernobrovkin, …
    Year: 2012
    Citations: 56

  • Title: Plasma exosomes stimulate breast cancer metastasis through surface interactions and activation of FAK signaling
    Authors: T Shtam, S Naryzhny, R Samsonov, D Karasik, I Mizgirev, A Kopylov, …
    Year: 2019
    Citations: 52

  • Title: Blue Dry Western: Simple, economic, informative, and fast way of immunodetection
    Authors: SN Naryzhny
    Year: 2009
    Citations: 52

  • Title: Protein profiles of the Chinese hamster ovary cells in the resting and proliferating stages
    Authors: SN Naryzhny, H Lee
    Year: 2001
    Citations: 51

  • Title: Virtual-experimental 2DE approach in chromosome-centric human proteome project
    Authors: SN Naryzhny, MA Maynskova, VG Zgoda, NL Ronzhina, OA Kleyst, …
    Year: 2016
    Citations: 41

  • Title: Combination of virtual and experimental 2DE together with ESI LC‐MS/MS gives a clearer view about proteomes of human cells and plasma
    Authors: SN Naryzhny, VG Zgoda, MA Maynskova, SE Novikova, NL Ronzhina, …
    Year: 2016
    Citations: 40

  • Title: Characterization of the human proliferating cell nuclear antigen physico-chemical properties: aspects of double trimer stability
    Authors: SN Naryzhny, LV DeSouza, KWM Siu, H Lee
    Year: 2006
    Citations: 40

  • Title: Haptoglobin as a biomarker
    Authors: SN Naryzhny, OK Legina
    Year: 2021
    Citations: 39